New: Hyperplex Biomarker Panels
Custom Panels for Absolute Protein Quantification
New: Hyperplex Biomarker Panels
Custom Panels for Absolute Protein Quantification
Immunopeptides play an essential role in adaptive immunity by activating and ensuring T-cell specificity. Mass spectrometry (MS) is currently the only technology that can reliably measure and identify the immunopeptide profiles of biological samples at a large scale. However, quality of data in these assays is limited by sample input, extraction efficiency, and poor scalability. To address this issue, we optimized the native lysis of cells with AFA-based ultrasonication and immunoprecipitation while ensuring 96-well compatibility, scalability and reproducibility. Post MS data acquisition, the data was processed using SpectroMine for spectral library generation and Spectronaut for library-based data extraction. With the optimized workflow, we can now identify over 2,800 class-I immunopeptides with 2.5 mg healthy lung tissue and >11,000 class-I and >10,000 class-II immunopeptides with 15 mg fresh frozen tissue. Overall, we have established a scalable, efficient pipeline for cell line and tissue immunopeptidomics for both class-I and II immunopeptides. The workflow described in this presentation will demonstrate generation of high-quality identifications from minimal starting material and can be deployed to help shed light on immunopeptidomics heterogeneity through large-scale profiling of patients as it will be exemplified in the case of neoantigen identification in MSI-high colorectal cancer.
Covaris Adaptive Focused Acoustics® (AFA®) is an advanced acoustic technology enabling the mechanical processing of samples through focused ultrasonication. With highly tunable energy, it gently disrupts the cell membranes of mammalian cells (e.g., GPCR assays), or abruptly disrupts the cell walls of bacteria (e.g., total protein extraction). AFA provides the flexibility to homogenize cells and efficiently extract proteins, RNA, DNA, Metabolites, or other targets in buffers optimized for downstream analytical methods.
Short Bio Marco Tognetti, PhD (Biognosys)
Dr. Tognetti is a principal scientist at Biognosys. He leads the R&D development of novel sample-processing solutions to enable deep, robust, and scalable proteome profiling. Most notably, he has recently contributed to deep plasma profiling and immunopeptide enrichment approaches and has developed optimized and automated workflows for large-scale proteomics. Dr. Tognetti obtained his B.Sc., M.Sc., and Ph.D. from ETH Zurich. Before joining Biognosys in 2020, his research at ETH Zurich and the University of Zurich brought him to integrate multiomics approaches to improve drug response prediction in breast cancer.
Short Bio Nicolas Autret, PhD (Covaris)
Nicolas Autret earned a PhD in Microbiology from Université Paris 7 in 2003. He’s been holding several commercial roles in the past 16 years for different companies and his fields of expertise are biochemistry, molecular biology and cell culture. He works for Covaris since April 2018 as senior business development manager and he is responsible for the development of new applications in the field of protein analysis, using Covaris AFA technology. Recently, he set up collaborations with world leading mass spectrometry labs, including Jeroen Krijgsveld’s lab, to help establish high throughput sample preparation workflows for research and clinical proteomics.
The webinar will be available for unlimited on-demand viewing after the live event.
Biognosys AG
Wagistrasse 21
8952 Schlieren
Switzerland
Phone: +41 44 738 20 40
US Offices
Biognosys Inc
70 Bridge St, Suite 104
Newton, MA 02458
United States
